Certain A Shares of TianJin JinRong TianYu Precision Machinery Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2024. marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Twenty years of on-and-off government discussions have yielded little progress toward the goal of coordinating urban and industrial development in a key Chinese megalopolis the region encompassing the nation's capital Beijing, neighboring Hebei province, and the port-manufacturing-financial services city of Tianjin.Now, central government authorities have intervened with clear
ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years.ESR1 mutations are
The Menarini Group and SciClone Pharmaceuticals: Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Menarini Industrie Farmaceutiche Riunite: Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.